minoxidil has been researched along with Dermatitis Medicamentosa in 16 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 7.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
| "After more than a decade of use, topical minoxidil solution has proven to be a safe and effective treatment for androgenetic alopecia." | 7.71 | Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. ( Cohen, DE; Friedman, ES; Friedman, PM; Washenik, K, 2002) |
| "5% anthralin was used to treat 51 patients with severe treatment-resistant alopecia areata." | 7.68 | Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. ( DeVillez, RL; Fiedler, VC; Metzler, C; Szpunar, GJ; Wendrow, A, 1990) |
| "Treatment with minoxidil can induce an increase in hair density and hair thickness,whereas treatment with alfatradiol results in deceleration or stabilization of hair loss." | 6.73 | Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. ( Blume-Peytavi, U; Ellwanger, U; Garcia Bartels, N; Hoffmann, R; Krisp, A; Kunte, C, 2007) |
| "Minoxidil was withdrawn and the patient responded to therapy with topical corticosteroids." | 5.27 | Pruritic rash with actinic keratosis and impending exfoliation in a patient with hypertension managed with minoxidil. ( Ackerman, BH; Bryan, AB; Golden, W; Townsend, ME, 1988) |
| "Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 3.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
| "After more than a decade of use, topical minoxidil solution has proven to be a safe and effective treatment for androgenetic alopecia." | 3.71 | Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. ( Cohen, DE; Friedman, ES; Friedman, PM; Washenik, K, 2002) |
| "5% anthralin was used to treat 51 patients with severe treatment-resistant alopecia areata." | 3.68 | Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. ( DeVillez, RL; Fiedler, VC; Metzler, C; Szpunar, GJ; Wendrow, A, 1990) |
| "Treatment with minoxidil can induce an increase in hair density and hair thickness,whereas treatment with alfatradiol results in deceleration or stabilization of hair loss." | 2.73 | Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. ( Blume-Peytavi, U; Ellwanger, U; Garcia Bartels, N; Hoffmann, R; Krisp, A; Kunte, C, 2007) |
| "Minoxidil was withdrawn and the patient responded to therapy with topical corticosteroids." | 1.27 | Pruritic rash with actinic keratosis and impending exfoliation in a patient with hypertension managed with minoxidil. ( Ackerman, BH; Bryan, AB; Golden, W; Townsend, ME, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guarneri, C | 1 |
| Cannavò, SP | 1 |
| Hagemann, T | 1 |
| Schlütter-Böhmer, B | 1 |
| Allam, JP | 1 |
| Bieber, T | 1 |
| Novak, N | 1 |
| Rodríguez-Martín, M | 1 |
| Sáez-Rodríguez, M | 1 |
| Carnerero-Rodríguez, A | 1 |
| Cabrera de Paz, R | 1 |
| Sidro-Sarto, M | 1 |
| Pérez-Robayna, N | 1 |
| Guimerá, F | 1 |
| Sánchez, R | 1 |
| García-Bustínduy, M | 1 |
| Noda-Cabrera, A | 1 |
| Blume-Peytavi, U | 1 |
| Kunte, C | 1 |
| Krisp, A | 1 |
| Garcia Bartels, N | 1 |
| Ellwanger, U | 1 |
| Hoffmann, R | 1 |
| Ebner, H | 1 |
| Müller, E | 1 |
| Fisher, AA | 2 |
| Friedman, ES | 1 |
| Friedman, PM | 1 |
| Cohen, DE | 1 |
| Washenik, K | 1 |
| Whitmore, SE | 1 |
| Wilson, C | 1 |
| Walkden, V | 1 |
| Powell, S | 1 |
| Shaw, S | 1 |
| Wilkinson, J | 1 |
| Dawber, R | 1 |
| Fiedler, VC | 1 |
| Wendrow, A | 1 |
| Szpunar, GJ | 1 |
| Metzler, C | 1 |
| DeVillez, RL | 1 |
| Jeremías Torruella, FJ | 1 |
| Giménez Camarasa, JM | 1 |
| Degreef, H | 1 |
| Hendrickx, I | 1 |
| Dooms-Goossens, A | 1 |
| van der Willigen, AH | 1 |
| Dutrée-Meulenberg, RO | 1 |
| Stolz, E | 1 |
| Geursen-Reitsma, AM | 1 |
| van Joost, T | 1 |
| Valsecchi, R | 1 |
| Cainelli, T | 1 |
| Ackerman, BH | 1 |
| Townsend, ME | 1 |
| Golden, W | 1 |
| Bryan, AB | 1 |
1 review available for minoxidil and Dermatitis Medicamentosa
| Article | Year |
|---|---|
The importance of proper vehicle selection in the detection of minoxidil sensitivity.
Topics: Adult; Drug Eruptions; Humans; Male; Minoxidil; Patch Tests; Pharmaceutical Vehicles | 1992 |
3 trials available for minoxidil and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Topics: Administration, Topical; Alopecia; Drug Eruptions; Estradiol; Female; Germany; Hair; Humans; Middle | 2007 |
Contact dermatitis in reaction to 2% topical minoxidil solution.
Topics: Administration, Topical; Adult; Alopecia; Dermatitis, Contact; Double-Blind Method; Drug Eruptions; | 1991 |
Topical minoxidil sensitization in androgenic alopecia.
Topics: Administration, Topical; Alopecia; Clinical Trials as Topic; Double-Blind Method; Drug Eruptions; Hu | 1987 |
12 other studies available for minoxidil and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Erosive pustular dermatosis of the scalp from topical minoxidil 5% solution.
Topics: Aged; Alopecia; Dermatologic Agents; Drug Eruptions; Female; Humans; Minoxidil; Scalp; Scalp Dermato | 2013 |
Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
Topics: Administration, Topical; Aged; Alopecia; Dermatitis, Allergic Contact; Drug Eruptions; Female; Human | 2005 |
Pustular allergic contact dermatitis from topical minoxidil 5%.
Topics: Adult; Dermatitis, Allergic Contact; Drug Eruptions; Forehead; Humans; Male; Minoxidil; Scalp; Vasod | 2007 |
Allergic contact dermatitis from minoxidil.
Topics: Administration, Topical; Adult; Alopecia; Dermatitis, Allergic Contact; Drug Eruptions; Humans; Male | 1995 |
Unusual acute, nonallergic eruptions of the scalp from combined use of minoxidil and retinoic acid.
Topics: Drug Eruptions; Erythema; Granuloma; Humans; Male; Middle Aged; Minoxidil; Scalp Dermatoses; Tretino | 1993 |
Allergic contact dermatitis to topical minoxidil solution: etiology and treatment.
Topics: Administration, Topical; Aged; Alopecia; Dermatitis, Allergic Contact; Drug Eruptions; Female; Follo | 2002 |
Use of glycerin in topical minoxidil solutions for patients allergic to propylene glycol.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Female; Glycerol; Humans; Male; Mino | 1990 |
Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin.
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anthralin; Child; Drug Combinations; Dr | 1990 |
[Allergenicity degree and sensitization percentage of minoxidil in experimental animals].
Topics: Animals; Animals, Laboratory; Biopsy; Drug Eruptions; Guinea Pigs; Minoxidil | 1990 |
Allergic contact dermatitis to minoxidil.
Topics: Adult; Alopecia; Drug Eruptions; Female; Humans; Minoxidil; Patch Tests; Scalp Dermatoses | 1985 |
Allergic contact dermatitis from minoxidil.
Topics: Adult; Alopecia; Drug Eruptions; Facial Dermatoses; Humans; Male; Minoxidil; Patch Tests; Scalp Derm | 1987 |
Pruritic rash with actinic keratosis and impending exfoliation in a patient with hypertension managed with minoxidil.
Topics: Drug Eruptions; Humans; Hypertension; Keratosis; Male; Middle Aged; Minoxidil; Pruritus | 1988 |